Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison

Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison

Background: Cytokine storm is a marker of severity and severe mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia. Immunomodulatory treatments may reduce morbidity and mortality. Objectives: To determine whether a 7-day course of methylprednisolone (MP) administered with and wit...

Full description

Bibliographic Details
Main Authors: Dujana Mostafa Hamed, Khawla Mohammad Belhoul, Naama Abdelrahman Al Maazmi, Farah Ghayoor, Muneeba Moin, Mahra Al Suwaidi, Meeruna Narainen, Maryam Makki, Mahera AbdulRahman
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Journal of Infection and Public Health
Subjects:
Methylprednisolone therapy
Severe COVID-19 pneumonia
Tocilizumab
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034121001581

Internet

http://www.sciencedirect.com/science/article/pii/S1876034121001581

Similar Items